September 26, 2017
ADC Bio to invest $11m on Bioconjugation facility
ADC Biotechnology has secured investment for the construction of a bioconjugation facility at its new site in Deeside, North Wales,…
Pharmaceuticals, Biotechnology and Life Sciences
Author: Dino Mustafić
September 26, 2017
Janssen files NDA to U.S. FDA for the first Darunavir-based tablet for HIV-1
Janssen has submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for darunavir several doses, for…
September 25, 2017
Targovax protects its neoantigen vaccines in USA for RAS-mutated cancers
Targovax has obtained the patent from the US Patent and Trademark Office for it’s mutant-RAS specific neoantigen vaccines, TG01 and…
September 22, 2017
Novartis and The Max Foundation transform pioneering cancer access program for people in lower-income countries
Novartis has enterned in new collaboration with The Max Foundation to support continued access to treatment at no cost for nearly 34,000 current patients with chronic myeloid leukemia (CML), gastrointestinal tumors (GIST) and other rare cancers.
September 21, 2017
Sanofi, Alnylam’s ATTR amyloidosis study meets main goal
Sanofi’s speciality care unit Genzyme together with an RNAi therapeutics company Alnylam Pharmaceuticals, announced Wednesday that the APOLLO Phase 3…
September 20, 2017
EC approves Novartis’s cancer drug for 2 indications
The European Commission has approved Novartis’s Rydapt for two indications in rare cancers, in combination with standard daunorubicin and cytarabine…
September 19, 2017
Alkermes gets good results testing Aristada for schizophrenia
Alkermes revealed positive results from a phase 4 clinical study of its schizophrenia injectable drug Aristada. Alkermes said on Monday…
September 18, 2017
Allergy Therapeutics wins approval for PQ Grass phase II trial
Allergy Therapeutics, a pharmaceutical group specialising in allergy vaccines, has announced that the fully-funded Phase II clinical trial investigating the dosing of PQ Grass has received clinical trial application (CTA) approval.
September 15, 2017
EMA’s CHMP says No to Santhera’s Raxone in DMD, appeal on the way
Santhera Pharmaceuticals said on Friday that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency…
September 15, 2017
Nordic Star Awards was presented at the NLSDays conference
Herantis Pharma, Targovax, Pelago get the Nordic Stars Award at the Nordic Life Sciences Days in Malmö, Sweden. Nordic Stars…